The Sunshine Act: commercial conflicts of interest and the limits of transparency.
作者信息
Wilson Mark
机构信息
Mark Wilson is a bioethicist living in Guelph, Ontario, Canada.
出版信息
Open Med. 2014 Jan 14;8(1):e10-3. eCollection 2014.
Abstract
摘要
相似文献
1
The Sunshine Act: commercial conflicts of interest and the limits of transparency.《阳光法案》：商业利益冲突与透明度的局限
Open Med. 2014 Jan 14;8(1):e10-3. eCollection 2014.
2
Shadows amid sunshine: regulating financial conflicts in medical research.阳光中的阴影：规范医学研究中的财务冲突。
Chest. 2014 Feb;145(2):379-385. doi: 10.1378/chest.13-1719.
3
The Sunshine Act--effects on physicians.《阳光法案》——对医生的影响。
N Engl J Med. 2013 May 30;368(22):2054-7. doi: 10.1056/NEJMp1303523.
4
Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.阳光作为消毒剂——关于向医生披露行业付款的新规定。
N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090.
5
The Sunshine Act: it's for real now.《阳光法案》：现在它动真格了。
WMJ. 2013 Apr;112(2):96-7.
6
"Transparency reports" on industry payments to physicians and teaching hospitals.关于行业向医生和教学医院付款的“透明度报告”。
JAMA. 2012 Mar 14;307(10):1029-30. doi: 10.1001/jama.2012.211. Epub 2012 Feb 14.
7
The physician payments sunshine act: what the average radiologist and manager need to know.医师薪酬阳光法案：普通放射科医生和管理者需要了解的内容。
J Am Coll Radiol. 2013 Jun;10(6):449-51. doi: 10.1016/j.jacr.2012.12.024.
8
Shining a light on the Sunshine Act.解读《阳光法案》。
J Med Assoc Ga. 2013;102(2):28.
9
The Physician Payment Sunshine Act: testing the value of transparency.《医师薪酬阳光法案》：检验透明度的价值。
JAMA. 2015 Jan 6;313(1):23-4. doi: 10.1001/jama.2014.15472.
10
Already feeling the heat: Docs rethinking payments as Sunshine Act looms.已然感受到压力：随着《阳光法案》临近，医生们重新思考薪酬问题。
Mod Healthc. 2013 Jul 1;43(26):12-3.
引用本文的文献
1
Disclosure of Industry Relationships by Otolaryngologists.耳鼻喉科医生的行业关系披露
Otolaryngol Head Neck Surg. 2025 Jun;172(6):1911-1918. doi: 10.1002/ohn.1223. Epub 2025 Mar 19.
2
'You feel like you've been duped': is the current system for health professionals declaring potential conflicts of interest in the UK fit for purpose? A mixed methods study.“你觉得自己好像被骗了”：英国现行的健康专业人员申报潜在利益冲突的制度是否合理？一项混合方法研究。
BMJ Open. 2023 Jul 26;13(7):e072996. doi: 10.1136/bmjopen-2023-072996.
3
COVID-19 Vaccine Task Force and Conflicts of Interest.COVID-19 疫苗工作组与利益冲突。
Healthc Policy. 2022 Feb;17(3):20-27. doi: 10.12927/hcpol.2022.26732.
4
Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.阳光照耀 KOLs：评估 2014 年至 2019 年法国专业医学协会领导人和制药行业之间财务联系的性质、程度和演变：一项回顾性研究。
BMJ Open. 2022 Feb 2;12(2):e051042. doi: 10.1136/bmjopen-2021-051042.
5
Despise the free lunch.别指望有免费的午餐。
Saudi J Gastroenterol. 2021 Nov-Dec;27(6):317-318. doi: 10.4103/sjg.sjg_541_21.
6
Looking Upstream: Promoting Health Equity in Philadelphia through Novel Partnership Strategies.溯源：通过新型合作策略促进费城的健康公平
Popul Health Manag. 2021 Dec;24(6):635-637. doi: 10.1089/pop.2021.0217. Epub 2021 Aug 26.
7
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.一缕阳光：医生-行业关系的透明度还不够。
J Gen Intern Med. 2021 Oct;36(10):3194-3198. doi: 10.1007/s11606-021-06657-0. Epub 2021 Mar 10.
8
Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing.阿片类药物危机的驱动因素：在阿片类药物处方高峰期评估临床实践指南小组中的财务利益冲突。
PLoS One. 2020 Jan 24;15(1):e0227045. doi: 10.1371/journal.pone.0227045. eCollection 2020.
9
Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.皮肤科患者倡导组织中潜在利益冲突的流行和披露。
JAMA Dermatol. 2019 Apr 1;155(4):460-464. doi: 10.1001/jamadermatol.2018.5102.
10
If we want things to change, we need to eliminate commercial conflicts of interest.
J R Soc Med. 2015 Apr;108(4):122. doi: 10.1177/0141076814563246.
本文引用的文献
1
Why we can't trust clinical guidelines.为什么我们不能信任临床指南。
BMJ. 2013 Jun 14;346:f3830. doi: 10.1136/bmj.f3830.
2
Should clinician-researchers disclose financial incentives to patients?临床研究人员应该向患者披露经济激励措施吗？
Virtual Mentor. 2002 Oct 1;4(10):virtualmentor.2002.4.10.jdsc1-0210. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
3
The dark side of the sun.太阳的阴暗面。
BMJ. 2011 Nov 1;343:d7024. doi: 10.1136/bmj.d7024.
4
Letting the sunshine in on doctor-pharma relationships.让医生与制药公司的关系更加透明。
BMJ. 2011 Oct 11;343:d6459. doi: 10.1136/bmj.d6459.
5
Perspective: Disclosing hidden sources of funding.观点：披露隐藏的资金来源。
Acad Med. 2009 Sep;84(9):1226-8. doi: 10.1097/ACM.0b013e3181b18835.
6
Commentary: Disclosure's failings: what is the alternative?评论：信息披露的不足：还有什么其他选择？
Acad Med. 2009 Sep;84(9):1180-1. doi: 10.1097/ACM.0b013e3181b17e93.
7
Has the hunt for conflicts of interest gone too far? Yes.对利益冲突的追查是否过头了？答案是肯定的。
BMJ. 2008 Mar 1;336(7642):476. doi: 10.1136/bmj.39493.489213.AD.
8
Managing ethical performance in organizations: insights from the corporate world.
Cleve Clin J Med. 2007 Mar;74 Suppl 2:S73-6; discussion S77-80. doi: 10.3949/ccjm.74.suppl_2.s73.
9
Why disclosure?为何要披露？
J Gen Intern Med. 2006 Sep;21(9):1003-4. doi: 10.1111/j.1525-1497.2006.00581.x.
10
A trial of disclosing physicians' financial incentives to patients.一项向患者披露医生经济激励措施的试验。
Arch Intern Med. 2006 Mar 27;166(6):623-8. doi: 10.1001/archinte.166.6.623.
Zotero 插件